Plasmodium parasitophorous vacuole membrane protein Pfs16 promotes malaria transmission by silencing mosquito immunity
Journal of Biological Chemistry · 2023
DOI: 10.1016/j.jbc.2023.104824 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Julian Ramelow und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Sciences Graduate Program, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, USA. Hauptthemen laut MEDLINE: Anopheles, Malaria, Falciparum, Plasmodium falciparum, Protozoan Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
With rising cases for the first time in years, malaria remains a significant public health burden. The sexual stage of the malaria parasite infects mosquitoes to transmit malaria from host to host. Hence, an infected mosquito plays an essential role in malaria transmission. Plasmodium falciparum is the most dominant and dangerous malaria pathogen. Previous studies identified a sexual stage-specific protein 16 (Pfs16) localized to the parasitophorous vacuole membrane. Here, we elucidate the function of Pfs16 during malaria transmission. Our structural analysis identified Pfs16 as an alpha-helical integral membrane protein with one transmembrane domain connecting to two regions across parasitophorous vacuole membrane. ELISA assays showed that insect cell-expressed recombinant Pfs16 (rPfs16) interacted with Anopheles gambiae midguts, and microscopy found that rPfs16 was bound to midgut epithelial cells. Transmission-blocking assays demonstrated that polyclonal antibodies against Pfs16 significantly reduced the number of oocysts in mosquito midguts. However, on the contrary, feeding rPfs16 increased the number of oocysts. Further analysis revealed that Pfs16 reduced the activity of mosquito midgut caspase 3/7, a key enzyme in the mosquito Jun-N-terminal kinase immune pathway. We conclude that Pfs16 facilitates parasites to invade mosquito midguts by actively silencing the mosquito's innate immunity through its interaction with the midgut epithelial cells. Therefore, Pfs16 is a potential target to control malaria transmission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Sciences Graduate Program, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, USA.
- Department of Biological Sciences, Florida International University, Miami, Florida, USA.
- Biomedical Sciences Graduate Program, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, USA; Department of Biological Sciences, Florida International University, Miami, Florida, USA…
Förderung
- NIAID NIH HHS
- National Institutes of Health
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases
Zitieren
APA
Ramelow, J., Keleta, Y., Niu, G., Wang, X., & Li, J. (2023). Plasmodium parasitophorous vacuole membrane protein Pfs16 promotes malaria transmission by silencing mosquito immunity. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.104824
Vancouver
Ramelow J, Keleta Y, Niu G, Wang X, Li J. Plasmodium parasitophorous vacuole membrane protein Pfs16 promotes malaria transmission by silencing mosquito immunity. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.104824
BibTeX
@article{Ramelow2023,
author = {Ramelow, Julian and Keleta, Yacob and Niu, Guodong and Wang, Xiaohong and Li, Jun},
title = {Plasmodium parasitophorous vacuole membrane protein Pfs16 promotes malaria transmission by silencing mosquito immunity},
journal = {Journal of Biological Chemistry},
year = {2023},
doi = {10.1016/j.jbc.2023.104824}
}
EUVIMED